CME Oncology Conferences
IDEOlogy Health is elevating the traditional model of educational meetings by selecting world-renowned faculty, practice-changing agenda topics, and interactive networking experience. We leverage unique venues to provide rich, unforgettable learning experiences for our attendees.
Texas Gastrointestinal Cancer Conference
November 5-7, 2026
ACL Live at the Moody Theater
Austin, TX
CHAIR
Yelena Janjigian, MD
Memorial Sloan Kettering Cancer Center
The 1st Annual Texas Gastrointestinal Cancer Conference will bring over 40 faculty members including leading national experts and community oncologists. The conference promises a distinctive learning experience covering a broad range of relevant topics in GI oncology.
CHAIR
Scott Paulson, MD
Texas Oncology, Baylor Sammons Cancer Center
World Conference On Genitourinary Cancers
December 3 – 5, 2026
Located at the Country Music Hall of Fame® and Museum
Nashville, TN
CHAIR
Alicia Morgans, MD, MPH, FASCO
Harvard Medical School
The 3rd annual World GU Conference, which will bring together 70+ esteemed faculty members in kidney, bladder, and prostate cancers. This impeccable ensemble of world-renowned thought leaders in the GU space spans the multidisciplinary spectrum, including leading national experts, community oncologists, and urologists.
CHAIR
Daniel George, MD
Duke Cancer Center
Nashville Hematology Conference
February 18 – 20, 2027
Located at the Country Music Hall of Fame® and Museum
Nashville, TN
CHAIR
Joanna Rhodes, MD, MSCE
Rutgers Cancer Institute of New Jersey
CHAIR
Jesús Berdeja, MD
Greco-Hainsworth Tennessee Oncology Centers for Research
CHAIR
Andrew Kuykendall, MD
Moffitt Cancer Center
The 3rd CME/CE-certified meeting will bring the top national experts together to discuss the latest updates and challenges in the management of hematologic malignancies with a special focus on translating the newest data into community practice.
CHAIR
Tina Cascone, MD, PhD
MD Anderson Cancer Center
The award-winning 2-day CME/CE event is designed to provide attendees with the knowledge needed to confidently navigate the increasingly complex field of lung cancer and its treatment landscape. Attendees will learn the current standards of care for targeted therapy and immunotherapy from the investigators driving the field.
CHAIR
Stephen Liu, MD
Georgetown University